Calcarea Combination
Generic Name: calcarea combination
Brand Names:
Calcarea Combination 9214
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS For the temporary relief of tender or aching bones.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS If symptoms do not improve or are accompanied by a fever, consult a doctor. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Calcarea Combination used for?▼
INDICATIONS For the temporary relief of tender or aching bones.*
Can I take Calcarea Combination during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Calcarea Combination?▼
WARNINGS If symptoms do not improve or are accompanied by a fever, consult a doctor. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Pertuzumab, Trastuzumab, And Hyaluronidase-zzxf
pertuzumab, trastuzumab, and hyaluronidase-zzxf
Endoglycosidase [EPC]
11 DESCRIPTION PHESGO is a combination of pertuzumab, trastuzumab, and hyaluronidase. Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). Pertuzumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture. Pertuzumab has an approximate molecular weight of 148 kDa.
Dexbrompheniramine Maleate, Dextromethorphan Hydrobromide And Pseudoephedrine Hydrochloride
dexbrompheniramine maleate, dextromethorphan hydrobromide and pseudoephedrine hydrochloride
Purpose Antihistamine Antitussive Nasal Decongestant
Delavirdine Mesylate
delavirdine mesylate
Manufactured by VIIV HLTHCARE. Dosage form: TABLET. Route: ORAL. Active ingredients: DELAVIRDINE MESYLATE (200MG). Application: NDA020705.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.